Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Mini-RISK in Agder: A Cluster Randomized Controlled Trial of a Low-Threshold School-Based Program for Anxious Students Delivered by School Personnel in the School Setting

12 de novembro de 2026 atualizado por: Sorlandet Hospital HF

The goal of this clinical trial is to learn if Mini-RISK, a short group program at school, reduces anxiety in young people aged 12 to 16 more than the usual help they get from the school nurse.

The main question it aims to answer is:

Does Mini-RISK lower anxiety symptoms more than usual school nurse support, measured 8 weeks after the start?

Other questions are:

Does Mini-RISK improve quality of life, school attendance and school functioning? Does Mini-RISK reduce the ways families and schools help young people avoid what they fear (called accommodation)? Which young people benefit most, for example depending on how they handle uncertainty, how their family functions, bullying, and social media use?

About 70 schools in 10 municipalities in Agder, Norway, were assigned by chance (like drawing lots) to offer either Mini-RISK or usual school nurse support. Young people who seek help for anxiety at school get the help their school offers. Researchers will compare the two groups to see if Mini-RISK works better than usual support.

In Mini-RISK, groups of 4 to 6 young people meet at school for 8 sessions over 8 weeks (about 15.5 hours in total). The groups are led by a school nurse and a school social teacher who have been trained in the program. Parents take part in 4 sessions and contact teachers in 2. Young people learn about anxiety and practice, step by step, facing situations they fear, with support from parents and teachers.

Usual support means individual follow-up from the school nurse, such as supportive conversations, adjustments at school and referral to other services when needed.

Participants and their parents will:

Fill out online questionnaires at the start, after 8 weeks, after 22 weeks and after 12 months (about 15 to 20 minutes each time) Answer a short questionnaire (about 5 minutes) each week during the 8-week program period

After the randomized part of the study, schools that offered usual support will also be trained in Mini-RISK, and data from these schools will be used to study who benefits most from the program.

Visão geral do estudo

Status

Recrutamento

Condições

Intervenção / Tratamento

Descrição detalhada

Background. Anxiety disorders affect 6 to 15% of young people and often impair school functioning, attendance and quality of life. Cognitive behavioral therapy (CBT) with exposure is the best documented treatment, but it is rarely available to anxious youth outside specialist services. In Norwegian schools, the most common help is supportive counseling by the school nurse, which has no documented effect. Schools also often accommodate anxiety, for example by exempting students from feared activities, which may maintain anxiety over time. Mini-RISK is a brief, school-based CBT group program developed at the Department of Child and Adolescent Mental Health, Sørlandet Hospital, as a low-threshold version of the RISK multi-family exposure program. It is delivered jointly by school health and school personnel, with active involvement of parents and contact teachers, and targets exposure and the reduction of family and school accommodation. Mini-RISK has been implemented in all 42 schools in Kristiansand municipality but has not been tested in a randomized trial.

Design. Cluster randomized controlled trial with schools as the unit of randomization. About 70 schools in 10 municipalities in Agder, Norway, were randomized in October 2025 to receive Mini-RISK training first (intervention) or to continue usual practice (business as usual, BAU) during the randomized phase. Randomization was stratified by school size and socioeconomic characteristics of the school district and performed in R by a member of the research team. Students receive the help offered at their school, and the trial follows the existing ways schools handle students who seek help.

Training and delivery. In Mini-RISK schools, two staff members, preferably a school nurse and a school social teacher, complete a 15-credit continuing education program at the University of Agder: 8 days of teaching and 23 hours of video-based supervision over one year, given by experienced RISK therapists and Mini-RISK group leaders. Local coordinators employed by each municipality support group leaders, recruitment and data collection. Usual support is expected to vary across schools and municipalities and remains the responsibility of each school.

Procedure. Students are recruited when they seek help for anxiety, or are encouraged to seek help, through the school nurse or social teacher, parent meetings and school information channels. A local coordinator assesses eligibility. Written information and consent are distributed through CheckWare, a secure platform approved by Sørlandet Hospital. Students aged 16 consent themselves; for students under 16, guardians consent and the student can decline. In BAU schools, follow-up starts immediately. In Mini-RISK schools, treatment starts when a group has been formed. Participants are encouraged not to seek other anxiety treatment during the intervention period unless clinically needed, and are referred onward if concerns arise. Assessments are completed digitally by youth and parents at baseline, weekly during the intervention period, at 8 weeks (primary endpoint, post-intervention), at 22 weeks and at 12 months.

Blinding. Participants and providers cannot be blinded, and outcomes are self- and parent-reported. Outcome analyses are performed by a statistician who has not been involved in recruitment or contact with participants, and who remains blinded to results until follow-up is complete.

Statistical analysis. Intention-to-treat analyses with multilevel (hierarchical) regression accounting for repeated measures within students and students within schools. Missing data are handled with full-information maximum likelihood. Moderation of effects is tested with interaction terms in the same framework. Session-to-session processes are analyzed with multilevel autoregressive cross-lagged models. Results are reported across all participating schools; no analyses will identify individual schools.

Sample size. The minimal important difference for the primary outcome is Cohen's d = 0.5. With alpha .05, power .80 and 20% missing data, 140 participants per arm are required. Predictor analyses (f² = 0.05) require 334 participants, and session-to-session analyses 180. With about 70 schools each including at least 4 participants per year over two years, about 640 participants are expected.

Open phase. After the randomized phase (2026 to 2028), BAU schools are trained in Mini-RISK, and data collection continues in all schools (2028 to 2030) to study predictors and moderators of outcome. Data from the open phase are not part of the randomized comparison.

Ethics and data. Approved by REK sør-øst A (964909). Data are pseudonymized, stored on a secure research server at Sørlandet Hospital, and handled in line with the GDPR.

Tipo de estudo

Intervencional

Inscrição (Estimado)

640

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • Vest-Agder
      • Kristiansand, Vest-Agder, Noruega, 4630
        • Recrutamento
        • Sørlandet Hospital, Department of Child and Adolescent Mental Health
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

10 anos a 16 anos (Filho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Age 10 to 16 years
  • Attends a participating school in one of the 10 participating municipalities in Agder, Norway
  • Seeks help, or is encouraged by adults to seek help, for anxiety at school
  • Score of 15 or higher on the Spence Children's Anxiety Scale, child version (SCAS-C)
  • Youth and parent(s) proficient in Norwegian
  • Written informed consent from both guardians for youth under 16 years (youth may decline participation), or from the youth for those aged 16 years
  • Willing to complete study questionnaires and to accept the intervention offered at their school

Exclusion Criteria:

  • Severe psychiatric conditions that would not normally be handled in the school setting (e.g., psychosis, suicidal ideation, self-harm, or anxiety severe enough to require specialist care)
  • Ongoing treatment in, or referral to, specialist mental health services
  • Drug or alcohol dependence
  • Developmental disorders, including autism spectrum disorder, or severe cognitive impairment
  • Known serious somatic disease needing medical treatment or likely to interfere with participation (e.g., cancer, epilepsy, moderate to severe traumatic brain injury)
  • Youth or parents unable to attend scheduled intervention sessions
  • Anxiety is not the main problem for which the youth and family need help (e.g., severe family conflict or dissolution, or ongoing external stressors such as bullying)

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Mini-RISK School-based group CBT

Schools randomized to Mini-RISK. Students receive Mini-RISK, a school-based cognitive behavioral group program for anxiety. Groups of 4 to 6 students meet at school for 8 sessions over 8 weeks (about 15.5 hours), plus a follow-up session after about 3 months. Groups are led by a school nurse and a school social teacher who have completed Mini-RISK training at the University of Agder (8 days of teaching and 23 hours of video-based supervision). Parents attend 4 sessions and contact teachers 2 sessions. Core elements are psychoeducation, graded exposure to feared situations (including two 3-hour group exposure sessions with parents), homework, and reducing unhelpful family and school accommodation of anxiety.

Manualized, low-threshold group CBT program for anxious youth, developed at the Department of Child and Adolescent Mental Health, Sørlandet Hospital, as a brief school-based version of the RISK multi-family exposure program. Unlike most CBT programs delivered by health professionals only, Mini-RISK is co-led by school health and school staff (a school nurse and a school social teacher) and actively involves parents and contact teachers. Youth attend sessions 2 to 8, parents sessions 1, 4, 6 and 8, and teachers sessions 1 and 8. Most session time is used for in-session exposure. Parents help each other's children during group exposure, and parents and teachers learn to reduce accommodation and to support exposure at home and at school. Group leaders receive ongoing supervision from experienced RISK therapists and Mini-RISK leaders.

Outros nomes:
  • Mini-RISK
Comparador Ativo: Usual School Nurse Support

Schools randomized to business as usual (BAU) during the randomized phase. Students receive the individual support the school nurse normally provides to students who seek help for anxiety. Support is needs-based and may include supportive conversations, assessment of needs, adjustments at school, involvement of parents, and referral to municipal or specialist services when needed. It is not manualized or time-limited and is expected to vary between schools and municipalities. No existing school services are removed or changed. These schools are trained in Mini-RISK after the randomized phase.

Individual support from the public school nurse as routinely provided in Norwegian schools to students who seek help for anxiety. Content and frequency are determined by the school nurse according to need and may include supportive counseling, needs assessment, school adjustments, contact with parents and teachers, and referral to other services. Not manualized, time-limited or anxiety-specific. Quality assurance is the responsibility of each school and municipality.

Outros nomes:
  • Business as usual (BAU)

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in Anxiety Symptoms (Spence Children's Anxiety Scale, Child Version, Total Score)
Prazo: Pre-post and Pre-12moFU

Youth-reported anxiety symptoms measured with the Norwegian version of the Spence Children's Anxiety Scale, child version (SCAS-C). The questionnaire has 44 items, of which 38 are scored on a 4-point scale (0 = never to 3 = always); 6 positive filler items are not scored. Total score range 0 to 114; higher scores indicate more severe anxiety. The difference between Mini-RISK and usual school nurse support in change from baseline to 8 weeks will be estimated with multilevel models accounting for clustering of students within schools (intention-to-treat).

Pre-post and Pre-12moFU
Change in Anxiety Symptoms (Spence Children's Anxiety Scale, Parent Version, Total Score)
Prazo: Pre-post and Pre-12moFU

Parent-reported anxiety symptoms of the child measured with the Norwegian version of the Spence Children's Anxiety Scale, parent version (SCAS-P). The questionnaire has 38 items scored on a 4-point scale (0 = never to 3 = always). Total score range 0 to 114; higher scores indicate more severe anxiety. The difference between Mini-RISK and usual school nurse support in change from baseline to 8 weeks will be estimated with multilevel models accounting for clustering of students within schools (intention-to-treat).

Pre-post and Pre-12moFU

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in Health-Related Quality of Life (KIDSCREEN-10 Index)
Prazo: Baseline, Post-treatment and 12moFU

KIDSCREEN-10 index, completed separately by youth (self-report) and parent (proxy report). 10 items rated on a 5-point scale, converted to Rasch-based T-scores (mean 50, SD 10); higher scores indicate better health-related quality of life. One additional item on general health is reported descriptively.

Baseline, Post-treatment and 12moFU
Change in School Attendance Problems (Inventory of School Attendance Problems, ISAP / ISAP-P)
Prazo: Baseline, Post-treatment and 12moFU

Completed separately by youth (ISAP) and parent (ISAP-P), items SP1 to SP10. Includes frequency of school absence in the last 12 school weeks (6 categories, from no absence to almost all the time), excused versus unexcused absence (visual analogue scale), and difficulty with 8 school-day situations (e.g., getting up, getting to school, entering the classroom) rated from "not at all" to "very much". Higher scores indicate more attendance problems.

Baseline, Post-treatment and 12moFU
Change in Self-Rated School Functioning (Single Item, 0 to 10)
Prazo: Baseline, Post-treatment and 12moFU

Single item adapted from the Work Ability Index (Kainulainen et al., 2023), completed separately by youth and parent: current school functioning compared with functioning at its best, rated 0 (cannot function at school at all) to 10 (school functioning at its best). Higher scores indicate better school functioning.

Baseline, Post-treatment and 12moFU
Change in Global Anxiety Severity (Clinical Global Impression-Severity, Adapted for Youth and Parent Report)
Prazo: Baseline, Post-treatment and 12moFU

Single item adapted from the Clinical Global Impression scale, completed separately by youth and parent: how much the youth has been troubled by anxiety in the past week, rated 1 (not troubled) to 7 (extremely troubled). Higher scores indicate more severe anxiety.

Baseline, Post-treatment and 12moFU
Change in Family Accommodation of Anxiety (Family Accommodation Scale-Anxiety, FASA)
Prazo: Baseline, Post-treatment and 12moFU

Parent-reported family accommodation of the child's anxiety. 13 items; the accommodation score is the sum of items 1 to 9 (participation and modification), each rated 0 (never) to 4 (daily), range 0 to 36. Higher scores indicate more accommodation. Items 1 to 9 are also collected weekly during the intervention period with a past-week time frame.

Baseline, Post-treatment and 12moFU
Change in Depressive Symptoms (Abbreviated Patient Health Questionnaire, 4 Items)
Prazo: Baseline, Post-treatment and 12moFU

Four items from the PHQ-9 selected according to Smith et al. (2025), completed separately by youth (self-report) and parent (report on the youth). Items rated 0 (not at all) to 3 (nearly every day); total 0 to 12. Higher scores indicate more depressive symptoms.

Baseline, Post-treatment and 12moFU
Change in Generalized Anxiety Symptoms (Abbreviated Generalized Anxiety Disorder Scale, 3 Items)
Prazo: Baseline, Post-treatment and 12moFU

Three items from the GAD-7 selected according to Smith et al. (2025), completed separately by youth and parent. Items rated 0 (not at all) to 3 (nearly every day); total 0 to 9. Higher scores indicate more anxiety symptoms.

Baseline, Post-treatment and 12moFU
Change in Intolerance of Uncertainty (7 Items From the Intolerance of Uncertainty Scale-12)
Prazo: Baseline, Post-treatment and 12moFU

Seven items selected from the IUS-12 (Carleton et al., 2007), completed separately by youth (self) and parent (self). Items rated 1 (not at all characteristic of me) to 5 (entirely characteristic of me); total 7 to 35. Higher scores indicate greater intolerance of uncertainty.

Baseline, Post-treatment and 12moFU
Change in Problematic Social Media Use (Bergen Social Media Addiction Scale)
Prazo: Baseline, Post-treatment and 12moFU

Youth-reported problematic social media use on the Bergen Social Media Addiction Scale (Andreassen et al., 2016). 6 items rated 1 (very rarely) to 5 (very often); total 6 to 30. Higher scores indicate more problematic use.

Baseline, Post-treatment and 12moFU

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

20 de novembro de 2026

Conclusão Primária (Estimado)

24 de dezembro de 2029

Conclusão do estudo (Estimado)

24 de dezembro de 2030

Datas de inscrição no estudo

Enviado pela primeira vez

12 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

12 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • REK-964909

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

De-identified individual participant data underlying the published results (outcome and baseline variables) will be shared with qualified researchers on reasonable request. Because participants come from small schools and municipalities where indirect identification is possible, data will not be made openly available unless they can be fully anonymized. Sharing requires approval from the Regional Committee for Medical and Health Research Ethics (REK) where applicable, a data processing or data transfer agreement with the responsible institution, and compliance with the GDPR. Aggregated data and analysis code will be made openly available on the Open Science Framework.

Prazo de Compartilhamento de IPD

From publication of the primary results until 5 years after the end of the project (31 December 2035), after which data will be deleted or anonymized in line with the REK approval.

Critérios de acesso de compartilhamento IPD

Requests from researchers with a methodologically sound proposal, sent to the principal investigator. Access is granted after review by the project group and approval of required ethics and data-protection agreements.

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA
  • ANALYTIC_CODE

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .